Search Results - "Lantinga, M."

Pharmacokinetics of ceftriaxone, gentamicin, meropenem and vancomycin in liver cirrhosis: a systematic review by Comce, M H, Weersink, R A, Beuers, U, van Hest, R M, Lantinga, M A

“…Patients with liver cirrhosis are prone to develop severe bacterial infections. Pharmacokinetics (PK) of antibiotics in cirrhosis are potentially affected by…”
Get full text

Systematic review: the management of hepatic cyst infection by Lantinga, M. A., Geudens, A., Gevers, T. J. G., Drenth, J. P. H.

“…Summary Background Cyst infection is a severe complication of hepatic cystic disease. However, an evidence‐based treatment strategy is not available. Aim To…”
Get full text

Ciprofloxacin penetration into infected hepatic cysts in autosomal dominant polycystic kidney disease: a case report by Bernts, L H P, Wallenburg, E, de Jonge, H J M, Schaap, B, Kusters, R, Overtoom, T T C, Brüggemann, R J M, Drenth, J P H, Lantinga, M A

Get full text

Hepatic cyst penetration of cefazolin in patients receiving aspiration sclerotherapy by Lantinga, M A, Wijnands, T F M, Te Morsche, R H M, de Sévaux, R G L, Kuipers, S, Allegaert, K, Burger, D, Drenth, J P H

“…Hepatic cyst infection is a potentially severe complication in cystic disease. Treatment demands effective antibiotic concentrations within the infected cyst…”
Get full text

Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease by Lantinga, M A, de Sévaux, R G L, Gevers, T J G, Oyen, W J G, de Fijter, J W, Soonawala, D, Zietse, R, Salih, M, Casteleijn, N F, Spithoven, E M, Meijer, E, Gansevoort, R T, Drenth On Behalf Of The Dipak Consortium, J P H

“…Cyst infection may occur in autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD). Antimicrobial agents…”
Get full text

Imminent ovarian failure in childhood cancer survivors by Lantinga, G.M., Simons, A.H.M., Kamps, W.A., Postma, A.

“…The aim of this study was to investigate reproductive history and the prevalence of imminent ovarian failure (IOF) in female childhood cancer survivors…”
Get full text

A New WHO International Reference Reagent for Use in Potency Assays of Inactivated Poliomyelitis Vaccine by Wood, D.J., Heath, A.B., Kersten, G.F.A., Hazendonk, T., Lantinga, M., Beuvery, E.C.

“…Assays of the potency of inactivated poliovirus vaccine require the use of an appropriate reference reagent. Preparation 91/574 was shown by international…”
Get full text

Immunogenicity of Trypsin treated Type 2 and Type 3 Poliovirus in Rats by Kersten, G.F.A., Lantinga, M., Hazendonk, T., Beuvery, E.C.

“…Oral polio vaccine will encounter the proteolytic enzyme trypsin during administration but inactivated polio vaccine not. To investigate the effect of trypsin…”
Get full text

Ciprofloxacin penetration into infected hepatic cysts in autosomal dominant polycystic kidney disease: a case report by Bernts, L H P, Wallenburg, E, de Jonge, H J M, Schaap, B, Kusters, R, Overtoom, T T C, Brüggemann, R J M, Drenth, J P H, Lantinga, M A

Get full text